论文部分内容阅读
目的:探讨肾复康胶囊对高血压肾病的临床的治疗效果。方法:选取2016年1月-2017年1月我院收治的高血压肾病60例,按照随机数字表法分为观察组和对照组,每组30例,对照组给予常规治疗,观察组在对照组的基础上给予肾复康胶囊,比较两组患者治疗后的临床效果。结果:观察组显效20例,有效8例,无效2例,总有效率93.33%;对照组显效13例,有效10例,无效7例,总有效率76.66%,组间比较差异有统计学意义(P<0.05)。两组均未发生严重不良反应。结论:肾复康对高血压肾病疗效显著,临床耐受好,值得推广应用。
Objective: To investigate the therapeutic effect of Shenfukang capsule on hypertensive nephropathy. Methods: From January 2016 to January 2017, 60 cases of hypertensive nephropathy admitted to our hospital were divided into observation group and control group according to the random number table method, 30 cases in each group. The control group was given routine treatment. In the control group, On the basis of the group given Shenfukang capsule, the clinical effect of the two groups were compared. Results: In the observation group, 20 cases were markedly effective, 8 cases were effective, 2 cases were ineffective and the total effective rate was 93.33%. In the control group, 13 cases were markedly effective, 10 cases were effective and 7 cases were ineffective. The total effective rate was 76.66% (P <0.05). No serious adverse reactions occurred in both groups. Conclusion: Shenfukang has significant curative effect on hypertensive nephropathy and good clinical tolerance, which is worth popularizing and applying.